🚨 www.tadeclinicagem.com.br/guia - Conheça o Guia TdC com 7 dias grátis 🚨

Marcela Belleza e Nathalie Santana conversam sobre quando repor testosterona.

Minutagem:

01:43 Indicações de reposição de testosterona

03:06 Como diagnosticar e classificar o hipogonadismo

14:08 Formulações de testosterona disponíveis no Brasil

22:40 Reposição de testosterona e o câncer de próstata

24:16 Reposição de testosterona e eventos cardiovasculares

27:23 Reposição de testosterona e fertilidade

30:12 Particularidades da prescrição 

31:26 Quando não realizar a reposição 

Referências: 
1. Layton, J Bradley et al. “Comparative Safety of Testosterone Dosage Forms.” JAMA internal medicine vol. 175,7 (2015): 1187-96. doi:10.1001/jamainternmed.2015.1573 2. Bhasin, Shalender et al. “Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.” The Journal of clinical endocrinology and metabolism vol. 103,5 (2018): 1715-1744. doi:10.1210/jc.2018-00229 3. Vigen, Rebecca et al. “Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.” JAMA vol. 310,17 (2013): 1829-36. doi:10.1001/jama.2013.280386 4. Bhasin, Shalender et al. “Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.” The Journal of clinical endocrinology and metabolism vol. 103,5 (2018): 1715-1744. doi:10.1210/jc.2018-00229 5. Corona, Giovanni et al. “Treatment of Functional Hypogonadism Besides Pharmacological Substitution.” The world journal of men's health vol. 38,3 (2020): 256-270. doi:10.5534/wjmh.190061 6. Corona, Giovanni et al. “European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology.” Andrology vol. 8,5 (2020): 970-987. doi:10.1111/andr.12770 7. Lincoff, A Michael et al. “Cardiovascular Safety of Testosterone-Replacement Therapy.” The New England journal of medicine vol. 389,2 (2023): 107-117. doi:10.1056/NEJMoa2215025